Accendra Health Share Price (NYSE: ACH)

$2.36

▲

0.16

(7.27%)

Live

Last updated on February 7, 2026 at 2:29 am IST

$₹

Check the interactive Accendra Health Stock chart to analyse performance

Accendra Health Inc Key Stats

Check Accendra Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.2
Today's High	$2.38
Today's Low	$2.22
Market Capitalization	$147.7M
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-17.41
PE Ratio	69.64
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-18447.13%

Stock Returns calculator for Accendra Health Stock including INR - Dollar returns

The Accendra Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Accendra Health investment value today

Current value as on today

₹1,00,000

Returns

₹0

(0%)

Returns from Accendra Health Stock

₹0 (0%)

Dollar Returns*

₹0 (0%)

Indian investors sentiment towards Accendra Health Stock

16500%

Period: Jan 7, 2026 to Feb 6, 2026. Change in 30 Days versus previous period

Search interest for Accendra Health Stock from India on INDmoney has increased by 16500% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Accendra Health Inc

Name
Holdings %
Name
Holdings %
BNP Paribas Arbitrage, SA
0.01%

Analyst Recommendation on Accendra Health Stock

Rating

Trend

Buy

66%Buy

20%Hold

13%Sell

Based on 15 Wall street analysts offering stock ratings for Accendra Health(by analysts ranked 0 to 5 stars)

Accendra Health Share Price Target

What analysts predicted

Upside of 514.83%

Target:

$14.51

Current:

$2.36

Accendra Health share price target is $14.51, a slight Upside of 514.83% compared to current price of $2.36 as per analysts' prediction.

Accendra Health Stock Insights

Price Movement
In the last 3 months, ACH stock has moved down by -71.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 681.91M → 697.26M (in $), with an average increase of 2.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -869.05M → -150.27M (in $), with an average increase of 478.3% per quarter
ACH vs CAH (1 yr)
In the last 1 year, Cardinal Health, Inc. has given 78.8% return, outperforming this stock by 150.6%
ACH vs CAH (3 yr)
In the last 3 years, Cardinal Health, Inc. has given 194.9% return, outperforming this stock by 266.7%

Accendra Health Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$9.2B	↓ 2.2%
Net Income	$-62.4M	↓ 85.73%
Net Profit Margin	-0.68%	↑ 3.96%

	FY20	Y/Y Change
Revenue	$8.5B	↓ 7.93%
Net Income	$29.9M	↓ 147.89%
Net Profit Margin	0.35%	↑ 1.03%

	FY21	Y/Y Change
Revenue	$9.8B	↑ 15.39%
Net Income	$221.6M	↑ 641.82%
Net Profit Margin	2.26%	↑ 1.91%

	FY22	Y/Y Change
Revenue	$10.0B	↑ 1.74%
Net Income	$22.4M	↓ 89.9%
Net Profit Margin	0.22%	↓ 2.04%

	FY23	Y/Y Change
Revenue	$10.3B	↑ 3.8%
Net Income	$-41.3M	↓ 284.47%
Net Profit Margin	-0.4%	↓ 0.62%

	FY24	Y/Y Change
Revenue	$10.7B	↑ 3.55%
Net Income	$-362.7M	↑ 778.15%
Net Profit Margin	-3.39%	↓ 2.99%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Revenue	$660.4M	↑ 3.54%
Net Income	$-31.9M	↑ 45.81%
Net Profit Margin	-4.83%	↓ 1.4%

	Q3 FY24	Q/Q Change
Revenue	$686.8M	↑ 4.0%
Net Income	$-12.8M	↓ 59.98%
Net Profit Margin	-1.86%	↑ 2.97%

	Q4 FY24	Q/Q Change
Revenue	$2.7B	↑ 292.53%
Net Income	$-296.1M	↑ 2218.84%
Net Profit Margin	-10.98%	↓ 9.12%

	Q1 FY25	Q/Q Change
Revenue	$2.6B	↓ 2.37%
Net Income	$-25.0M	↓ 91.56%
Net Profit Margin	-0.95%	↑ 10.03%

	Q2 FY25	Q/Q Change
Revenue	$681.9M	↓ 74.09%
Net Income	$-869.1M	↑ 3378.74%
Net Profit Margin	-127.44%	↓ 126.49%

	Q3 FY25	Q/Q Change
Revenue	$697.3M	↑ 2.25%
Net Income	$-150.3M	↓ 82.71%
Net Profit Margin	-21.55%	↑ 105.89%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.1B	↑ 5.41%

	FY20	Y/Y Change
Profit	$1.3B	↑ 13.5%

	FY21	Y/Y Change
Profit	$1.5B	↑ 18.14%

	FY22	Y/Y Change
Profit	$1.8B	↑ 20.69%

	FY23	Y/Y Change
Profit	$2.1B	↑ 16.36%

	FY24	Y/Y Change
Profit	$2.2B	↑ 4.42%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Profit	$316.0M	↑ 5.49%

	Q3 FY24	Q/Q Change
Profit	$331.8M	↑ 4.98%

	Q4 FY24	Q/Q Change
Profit	$579.8M	↑ 74.75%

	Q1 FY25	Q/Q Change
Profit	$526.0M	↓ 9.27%

	Q2 FY25	Q/Q Change
Profit	$324.6M	↓ 38.29%

	Q3 FY25	Q/Q Change
Profit	$322.2M	↓ 0.74%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$166.1M	↑ 43.69%
Investing Cash Flow	$-51.9M	↓ 93.64%
Financing Cash Flow	$-130.2M	↓ 118.57%

	FY20	Y/Y Change
Operating Cash Flow	$339.2M	↑ 104.25%
Investing Cash Flow	$80.1M	↓ 254.29%
Financing Cash Flow	$-379.4M	↑ 191.39%

	FY21	Y/Y Change
Operating Cash Flow	$124.2M	↓ 63.39%
Investing Cash Flow	$-53.6M	↓ 166.98%
Financing Cash Flow	$-129.5M	↓ 65.87%

	FY22	Y/Y Change
Operating Cash Flow	$325.0M	↑ 161.73%
Investing Cash Flow	$-1.8B	↑ 3264.68%
Financing Cash Flow	$1.5B	↓ 1256.26%

	FY23	Y/Y Change
Operating Cash Flow	$740.7M	↑ 127.91%
Investing Cash Flow	$-137.3M	↓ 92.39%
Financing Cash Flow	$-417.3M	↓ 127.88%

	FY24	Y/Y Change
Operating Cash Flow	$161.5M	↓ 78.2%
Investing Cash Flow	$-116.5M	↓ 15.1%
Financing Cash Flow	$-267.6M	↓ 35.88%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Operating Cash Flow	$116.1M	↓ 319.31%
Investing Cash Flow	$-35.2M	↑ 1780.75%
Financing Cash Flow	$-78.2M	↓ 246.74%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$27.3M	↓ 76.49%
Investing Cash Flow	$-27.2M	↓ 22.69%
Financing Cash Flow	$-199.6M	↑ 155.1%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$71.0M	↑ 160.01%
Investing Cash Flow	$-52.3M	↑ 92.37%
Financing Cash Flow	$-43.1M	↓ 78.41%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-35.1M	↓ 149.39%
Investing Cash Flow	$-48.2M	↓ 7.85%
Financing Cash Flow	$92.8M	↓ 315.28%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$37.6M	↓ 207.25%
Investing Cash Flow	$-52.9M	↑ 9.79%
Financing Cash Flow	$31.7M	↓ 65.83%

	Q3 FY25	Q/Q Change
Operating Cash Flow	$-172.5M	↓ 558.71%
Investing Cash Flow	$-39.5M	↓ 25.42%
Financing Cash Flow	$181.1M	↑ 471.3%

Accendra Health Technicals Summary

Sell

Neutral

Buy

Accendra Health is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Accendra Health Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accendra Health Inc	2.33%	-5.17%	-5.17%	-5.17%	-74.36%
Cardinal Health, Inc.	9.65%	44.09%	78.36%	184.26%	329.37%
Mckesson Corporation	16.24%	42.37%	60.79%	161.21%	421.11%
Henry Schein, Inc.	-1.46%	16.49%	-2.53%	-11.23%	8.79%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accendra Health Inc	69.64	69.64	NA	0.0	-184.47	0.0	NA	NA
Cardinal Health, Inc.	31.86	31.86	2.01	9.97	0.0	0.03	0.01	-12.1
Mckesson Corporation	25.84	25.84	1.0	38.68	0.0	0.05	0.0	-14.02
Henry Schein, Inc.	24.48	24.48	1.74	4.91	0.08	0.04	NA	28.35

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accendra Health Inc	Buy	$147.7M	-74.36%	69.64	0.0%
Cardinal Health, Inc.	Hold	$50.1B	329.37%	31.86	0.68%
Mckesson Corporation	Buy	$102.8B	421.11%	25.84	1.04%
Henry Schein, Inc.	Hold	$9.4B	8.79%	24.48	3.02%

About Accendra Health Inc

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.

Organization	Accendra Health
Employees	23200
CEO	Mr. Edward A. Pesicka
Industry	Non-Energy Minerals

Key Management of Accendra Health Inc

Name	Title
Mr. Edward A. Pesicka	President, CEO & Director
Mr. Jonathan A. Leon	Executive VP, CFO & Corporate Treasurer
Mr. Perry A. Bernocchi	Executive VP & COO
Mr. Heath H. Galloway	Executive VP, General Counsel & Corporate Secretary
Will Parrish	Vice President of Strategy of Corporate Development, & Investor Relations
Trudi Allcott	Director of Media Relations

Important FAQs about investing in ACH Stock from India :

What is Accendra Health share price today?

Accendra Health share price today is $2.36 as on February 7, 2026 at 2:29 am IST. Accendra Health share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Accendra Health share?

Accendra Health share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Accendra Health stock price today i.e. February 7, 2026 at 2:29 am IST is trending at $2.36, lower by 0% versus the 52 week high.

How to invest in Accendra Health Stock (ACH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Accendra Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accendra Health Shares that will get you 0.6356 shares as per Accendra Health share price of $2.36 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Accendra Health Stock (ACH) from India?

Indian investors can start investing in Accendra Health (ACH) shares with as little as ₹90.7125 or $1 (as of February 07, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹907.13 in Accendra Health stock (as per the Rupee-Dollar exchange rate as on February 07, 2026). Based on Accendra Health share’s latest price of $2.36 as on February 7, 2026 at 2:29 am IST, you will get 4.2373 shares of Accendra Health. Learn more about fractional shares .

What are the returns that Accendra Health has given to Indian investors in the last 5 years?

Accendra Health stock has given -74.36% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?